Clarkston Capital Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-4,000
| Closed | -$453K | – | 170 |
|
2022
Q4 | $453K | Hold |
4,000
| – | – | 0.01% | 123 |
|
2022
Q3 | $322K | Hold |
4,000
| – | – | 0.01% | 143 |
|
2022
Q2 | $298K | Hold |
4,000
| – | – | 0.01% | 149 |
|
2022
Q1 | $512K | Sell |
4,000
-12
| -0.3% | -$1.54K | 0.01% | 133 |
|
2021
Q4 | $539K | Buy |
4,012
+12
| +0.3% | +$1.61K | 0.01% | 116 |
|
2021
Q3 | $547K | Hold |
4,000
| – | – | 0.01% | 103 |
|
2021
Q2 | $427K | Hold |
4,000
| – | – | 0.01% | 111 |
|
2021
Q1 | $359K | Hold |
4,000
| – | – | 0.01% | 120 |
|
2020
Q4 | $370K | Hold |
4,000
| – | – | 0.01% | 95 |
|
2020
Q3 | $412K | Hold |
4,000
| – | – | 0.01% | 85 |
|
2020
Q2 | $405K | Hold |
4,000
| – | – | 0.01% | 80 |
|
2020
Q1 | $269K | Hold |
4,000
| – | – | 0.01% | 84 |
|
2019
Q4 | $219K | Buy |
+4,000
| New | +$219K | 0.01% | 92 |
|